Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis

Overview of attention for article published in Frontiers in oncology, December 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 24,705 followers.

Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis https://t.co/GGPA3r5XGJ https://t.co/Zn4BHficHS

Modest efficacy and tolerable toxicity for IO rechallenge in mRCC. Waiting for TINIVO2 trial recruitment and results.

RT @FrontOncology: New research: Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis: Introd…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.